Toggle light / dark theme

A new King’s-led study, published in the Proceedings of the National Academy of Sciences, has found that a single factor (a protein coding gene known as Sox8) can make non-ear cells adopt ear character during embryo development. The findings not only demonstrate how cell fate decisions are regulated in the embryo but may also inform reprogramming and regenerative strategies for the ear developmental malformations.

Responsible for the sense of hearing and balance, the inner ear is critically important for communication with the environment. In humans, developmental malformations of the ear have life-long consequences, while age-related hearing defects affect a large proportion of the population. Currently, there are no therapies that involve biological approaches—only hearing aids or , as how the ear normally develops is not fully understood and many of the controlling factors are poorly characterized.

Researchers from the Faculty of Dentistry, Oral and Craniofacial Sciences at King’s, in collaboration with colleagues from the Francis Crick Institute, explored the earliest steps in ear development to determine what causes cells to become ear cells, and what makes them different from cells which form other sense organs.

As meetings shifted online during the COVID-19 lockdown, many people found that chattering roommates, garbage trucks and other loud sounds disrupted important conversations.

This experience inspired three University of Washington researchers, who were roommates during the pandemic, to develop better earbuds. To enhance the speaker’s voice and reduce , “ClearBuds” use a novel microphone system and one of the first machine-learning systems to operate in real time and run on a smartphone.

The researchers presented this project June 30 at the ACM International Conference on Mobile Systems, Applications, and Services.

Machine learning is transforming all areas of biological science and industry, but is typically limited to a few users and scenarios. A team of researchers at the Max Planck Institute for Terrestrial Microbiology led by Tobias Erb has developed METIS, a modular software system for optimizing biological systems. The research team demonstrates its usability and versatility with a variety of biological examples.

Though engineering of biological systems is truly indispensable in biotechnology and , today machine learning has become useful in all fields of biology. However, it is obvious that application and improvement of algorithms, computational procedures made of lists of instructions, is not easily accessible. Not only are they limited by programming skills but often also insufficient experimentally-labeled data. At the intersection of computational and experimental works, there is a need for efficient approaches to bridge the gap between machine learning algorithms and their applications for biological systems.

Now a team at the Max Planck Institute for Terrestrial Microbiology led by Tobias Erb has succeeded in democratizing machine learning. In their recent publication in Nature Communications, the team presented together with collaboration partners from the INRAe Institute in Paris, their tool METIS. The application is built in such a versatile and modular architecture that it does not require computational skills and can be applied on different biological systems and with different lab equipment. METIS is short from Machine-learning guided Experimental Trials for Improvement of Systems and also named after the ancient goddess of wisdom and crafts Μῆτις, or “wise counsel.”

Remission of depression with new magnetic therapy:3.


Although she’d tried medications and therapy, Chase felt her symptoms get worse over the course of a few months. And she knew things were really getting serious when thoughts of suicide crept in.

That’s when her mother found research about a new type of treatment for depression called Stanford neuromodulation therapy, which uses magnetic fields to stimulate the brain. (It was previously referred to as Stanford accelerated intelligent neuromodulation therapy or SAINT.)

The treatment is similar to transcranial magnetic stimulation, a non-invasive therapy that’s been used to help treat depression for about 15 years.

The BA.5 variant is now the most dominant strain of COVID-19 in the country, according to the Centers for Disease Control and Prevention. And while it’s hard to get an exact count — given how many people are taking rapid tests at home — there are indications that both reinfections and hospitalizations are increasing.

For example: Some 31,000 people across the U.S. are currently hospitalized with the virus, with admissions up 4.5% compared to a week ago. And data from New York state shows that reinfections started trending upwards again in late June.

Brain-machine interfaces (BMIs) are devices that enable direct communication/translation between biological neuronal networks (e.g. a brain or a spine) and external machines. They are currently being used as a tool for fundamental neuroscience research and also for treating neurological disorders and for manipulating neuro-prosthetic devices. As remarkable as today’s BMIs are, however, the next generation BMIs will require new hardware and software with improved resolution and specificity in order to precisely monitor and control the activities of complex neuronal networks. In this talk, I will describe my group’s effort to develop new neuroelectronic devices enabled by silicon nanotechnology that can serve as high-precision, highly multiplexed interface to neuronal networks. I will then describe the promises, as well as potential pitfalls, of next generation BMIs. Hongkun Park is a Professor of Chemistry and Chemical Biology and a Professor of Physics at Harvard University. He is also an Institute Member of the Broad Institute of Harvard and MIT and a member of the Harvard Center for Brain Science and Harvard Quantum Optics Center. He serves as an associate editor of Nano Letters. His research interests lie in exploring solid-state photonic, optoelectronic, and plasmonic devices for quantum information processing as well as developing new nano-and microelectronic interfaces for living cells, cell networks, and organisms. Awards and honors that he received include the Ho-Am Foundation Prize in Science, NIH Director’s Pioneer Award, and the US Vannevar Bush Faculty Fellowship, the David and Lucile Packard Foundation Fellowship for Science and Engineering, the Alfred P. Sloan Research Fellowship, and the Camille Dreyfus Teacher-Scholar Award. This talk was given at a TEDx event using the TED conference format but independently organized by a local community.

Called primary amebic meningoencephalitis (PAM), the infection is caused by a microscopic single-celled free-living ameba found in warm freshwater called Naegleria fowleri.

The Missouri patient is currently being treated for PAM in an intensive care unit of a hospital.

The ameba is commonly found in warm freshwater such as lakes, rivers, and ponds; however, PAM is extremely rare. Since 1962, only 154 known cases have been identified in the United States. The only other case identified among a Missouri resident occurred in 1987, and currently, no additional suspected cases of PAM are being investigated in Missouri.

Scientists have spotted the building blocks of RNA at the center of the Milky Way. They published their findings in Frontiers in Astronomy and Space Sciences. According to the study, the researchers discovered some of those building blocks in a cloud that lies near the center of our galaxy.

The team of researchers discovered the building blocks of RNA in a molecular cloud known as G+0.693–0.027. The discovery, they say, could have implications on the theories about how life on Earth began. It could also shed more light on how life on other planets began, too.

RNA, or ribonucleic acid, is a molecule similar to DNA. It’s present in all living cells and even behaves similarly to the more well-known double-helix. Unlike DNA’s double-strand, though, RNA is only made up of a single strand. Its overall part in the origin of life is unclear. But, there is some evidence the building blocks of RNA could have preceded DNA.

Mike George’s proposal for an autonomous fleet of modular emergency vehicles that can be arranged to form an on-the-go hospital has been awarded third place in Dezeen’s Future Mobility Competition powered by Arrival.

Called National Health Network Modular Hospital System, George’s proposal features a network of modular autonomous vehicles that can be combined into purpose-built clusters to enable hospitals to grow, adapt and respond to emergencies as effectively and flexibly as required.

Each module has a chassis and mobile platform, which can be customised with various interior components to respond to different medical situations. Each interior is designed to foster patient accessibility and comfort, as well as safety.